This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation.
The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation.
UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior research because all patients at UCLA have had a pre-treatment multi-parametric MRI and Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results in more precise assessment of a target region of cancer for ablation which may, in turn, result in improved clinical outcomes.
Patient has undergone or has elected to undergo hemi-gland cryoablation at UCLA Low or intermediate risk prostate cancer (Gleason ≤ 7) or select high-risk patients (Gleason 8 prostate cancer). Prostate volume of ≤ 70 cc Ability to complete informed consent form
Exclusion criteria:
Medical contraindication to follow-up multi-parametric magnetic resonance imaging (mpMRI) or prostate biopsy Patients unable to tolerate general or regional anesthesia.
